Orexigen Therapeutics, Inc.

Robbins LLP Is Investigating the Directors and Officers of Orexigen Therapeutics, Inc.

Robbins LLP is investigating whether certain officers and directors of Orexigen Therapeutics, Inc. (NASDAQ: OREX) ("Orexigen") breached their fiduciary duties to shareholders. Orexigen focuses on the development of pharmaceutical product candidates for the treatment of obesity.

Orexigen shareholders who would like more information about their rights and potential remedies can complete the form below and we will contact you directly. You can also contact attorney Darnell R. Donahue at (800) 350-6003.

Send us a message for more information.

Additional Alerts for Shareholders

Close up of Businessman writing some data in notebook and working on laptop at the office.

GPGI, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that GPCI, Inc. (GPGI) (formerly CompoSecure) Misled Investors Regarding the Value and Benefits of the Husky Acquisition Robbins LLP informs stockholders

Read More »

Intuit Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Intuit Inc. (INTU) Misled Investors Regarding the Company’s Sustainability and Growth Robbins LLP informs stockholders that a class action was

Read More »
Free!
Skip to content